(Q35042732)

English

Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

based on heuristic

inferred from title

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

author name string

F M Russell

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

A Balloch

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

P V Licciardi

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

J R Carapetis

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

L Tikoduadua

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

L Waqatakirewa

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Y B Cheung

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

E K Mulholland

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

M L K Tang

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

4499-4506

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

8 July 2018

Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

8 July 2018

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

8 July 2018

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

8 July 2018

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

8 July 2018

Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

8 July 2018

Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

8 July 2018

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

8 July 2018

Correlates of immunity for pneumococcal conjugate vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

8 July 2018

Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

8 July 2018

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

8 July 2018

Invasive pneumococcal disease in Fiji: clinical syndromes, epidemiology, and the potential impact of pneumococcal conjugate vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

25 October 2018

Results from an inter-laboratory comparison of pneumococcal serotype-specific IgG measurement and critical parameters that affect assay performance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

25 October 2018

First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

25 October 2018

Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

25 October 2018

Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

25 October 2018

Laboratory correlates of protection against Haemophilus influenzae type b disease. Importance of assessment of antibody avidity and immunologic memory

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114163

25 October 2018

Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.038

7 January 2021

Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.038

7 January 2021

Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.038

7 January 2021

Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.038

7 January 2021

Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.038

7 January 2021

Antibodies to serotype 9V exhibit novel serogroup cross-reactivity following infant pneumococcal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.038

7 January 2021

Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21539882

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates

1 reference

https://pubmed.ncbi.nlm.nih.gov/21539882

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pneumococcal conjugate vaccine for childhood immunization--WHO position paper

1 reference

https://pubmed.ncbi.nlm.nih.gov/21539882

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2011.04.038

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35042732&oldid=2087482537"